Brain Monitoring Market Analysis and Forecast to 2031: By Product Type (Electroencephalography Devices, Magnetencephalography Devices, Transcranial Doppler Devices, Intracranial Pressure Monitor, Cerebral Oximeters, Magnetic Resonance Imaging Devices, Computerized Tomography Devices, Positron Emission Tomography Devices, Sleep Monitoring Devices, Electromyography Devices, Accessories), Procedure (Invasive, Non-invasive), Application (Epilepsy, Dementia, Parkinson’s Disease, Huntington’s Disease, Headache Disorders, Stroke, Traumatic Brain Injuries, Sleep Disorders, Other Diseases), and Region
The global brain monitoring market size was USD 5.4 billion in 2021 and it is anticipated to reach USD 10.1 billion in 2031, growing at a rate of 7.2% from 2022-2031.
Brain monitoring helps clinicians in monitoring the condition of the brain under the influence of anesthesia through bilateral data acquisition and processing of the EEG signals. Brain monitoring devices are used to monitor and diagnose neurological conditions by exploring the structure and function of the brain. This process involves the use of several brain monitoring devices. At present, there is an increase in the demand for electroencephalography devices among healthcare providers.
Brain Monitoring Market Scope and Structure Analysis
| Report Attribute | Details |
|---|---|
| Market Size in 2021 | $5.4 bn |
| Market Size in 2031 | $10.1 bn |
| Growth Rate (2021-31) | 7.2% |
| Historic Period | 2015-2020 |
| Forecast Period | 2022-2031 |
| Base Year | 2021 |
| Segments Covered | Product Type, Procedure, Application, and Region |
| Key Companies | Advanced Brain Monitoring, Inc., CAS Medical Systems, Inc., Compumedics Ltd., General Electric Company (GE Healthcare), Koninklijke Philips N.V. (Philips Healthcare), Medtronic Plc., Natus Medical Incorporated, Neural Analytics, Inc., Siemens AG, Cadwell Laboratories, Neurosoft Limited, Elekta A.B., InfraSacn, Inc., BrainScope Company, Inc. |
| Regional Scope | North America, Europe, Asia Pacific, Central & South America, Middle East & Africa |
| Analysis Coverage | Market Forecast, Competitive Landscape, Drivers, Trends, Restraints, Opportunities, Value-Chain, PESTLE, Key Events and Developments |
Market Trends and Drivers
The major factor boosting the growth of the market is the increasing incidence and prevalence of neurological disorders. The global incidence and prevalence of neurological disorders, like dementia, epilepsy, Parkinson’s disease, Huntington’s disease, headache disorders, multiple sclerosis, neuro infections, stroke, and cerebral palsy, have increased significantly during the last few years. Brain disorders, which comprise a combination of developmental, psychiatric, and neurodegenerative diseases, are a growing cause of morbidity worldwide. This can mainly be attributed to the growing geriatric population (by 2050, more than 20% of the global population is expected to be aged over 65 years). The American Medical Association (AMA) anticipates that at least 60% of individuals aged 65 years and above will be living with more than one chronic condition by 2030.
The rising incidences of these neurological disorders have made it extremely important to monitor brain and neurological function. Many neurological disorders and conditions are progressive, and their risk increases with age. Adding to that, the prevalence of other diseases and conditions, such as sickle-cell diseases and cardiac disorders, is also increasing. Cardiac procedures may sometimes affect the normal functioning of the brain, which is another factor driving the demand for brain monitoring devices.
Market Restraints & Challenges
One of the primary challenges in the growth of the global brain monitoring market is the high cost of complex brain monitoring procedures and devices. The high cost of brain monitoring surgeries and devices is a primary factor restraining the global brain monitoring market, majorly in developing countries with poor reimbursement policies. Brain monitoring devices are highly complex, and the procedures involving the use of these devices are generally expensive. For example, the average cost of a standard EEG is ~USD 200–700; this procedure can cost as high as USD 3,000 for extended monitoring. A dual-channel TCD costs approximately USD 3,000–3,200, and an ICP monitor costs approximately USD 340–500. Similarly, a single MEG system costs roughly USD 2.5–3 million. Owing to the high price, healthcare facilities, even in countries that show wide adoption of high-tech medical equipment, find it difficult to procure MEG devices. Moreover, the maintenance cost and other associated indirect expenses increase the total cost of ownership of these devices, so limiting their adoption.
Global Brain Monitoring Market Segmentation
The report analyses the brain monitoring market based on product type, procedure, application, and region.
Global Brain Monitoring Market by Product Type
On the basis of product type, it is segmented into electroencephalography devices, magnetoencephalography devices, transcranial doppler devices, intracranial pressure monitors, cerebral oximeters, magnetic resonance imaging devices, computerized tomography devices, sleep monitoring devices, electromyography devices, and accessories. The electroencephalography devices segment is likely to dominate the market during the forecast period. The surge in demand for the diagnosis of critical disorders such as epilepsy has further influenced companies to focus on the development of brain monitoring EEG devices.
Global Brain Monitoring Market by Procedure
On the basis of procedure, it is segmented into invasive and non-invasive. The non-invasive segment accounted for the fastest growth during the forecast period. The key factors such as rise in incidences of traumatic brain injuries coupled with a high acceptance rate of minimally invasive devices, and a low risk of mortality. This increases the demand for these products which propels the market growth.
Global Brain Monitoring Market by Application
On the basis of application, it is segmented into epilepsy, dementia, parkinson’s disease, huntington’s disease, headache disorders, stroke, traumatic brain injuries, sleep disorders, and other diseases. The epilepsy segment is anticipated to dominate the market during the forecast period. The key factors such as the increasing geriatric population and the rise in the prevalence of neurological disorders are boosting the growth of the market.
Geographical Analysis of Global Brain Monitoring Market
Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. North America accounted for the largest share of the global brain monitoring market. The key factors such as growing incidences of neurological diseases, a growing number of clinical trials of brain monitoring products, and the availability of medical reimbursement in the US.
Major Players of the Global Brain Monitoring Market
The global brain monitoring market report includes players such as Advanced Brain Monitoring, Inc. , CAS Medical Systems, Inc. , Compumedics Ltd. , General Electric Company (GE Healthcare) , Koninklijke Philips N.V. (Philips Healthcare) , Medtronic Plc. , Natus Medical Incorporated , NovaSignal , Siemens AG , Cadwell Laboratories , Neurosoft Limited , Elekta A.B. , InfraSacn, Inc. , BrainScope Company, Inc. among others.
COVID-19 Analysis
The state of urgency to combat the outbreak has led to a significant increase in the demand for remote monitoring and patient engagement solutions. Most hospitals/healthcare facilities are currently trying to expand patient monitoring to home care settings or other temporary setups with an aim to provide optimal care. COVID-19 has led to a significant surge in demand for ventilators, and manufacturers are currently focusing their efforts to meet the increasing need for ventilators. Comprising other respiratory devices, in contrast to the brain monitoring business, particularly owing to the focus of hospitals on setting up COVID-19 specific ICUs, along with the temporary suspension of manufacturing sites in highly affected regions worldwide.
Recent Developments
- September 2021, NeuroWave Systems Inc. announced the FDA clearance of its Neuro SENSE NS-901 Monitor- a new generation brain function monitor for assessing the adequacy of anesthesia and sedation in clinical settings.
- November 2021, Brain Scientific received FDA clearance for Next-Gen Neuro Cap EEG Headset, and advanced electroencephalogram electrodes array used to obtain rapid EEG’s in routine clinical and research settings where the recording of STAT EEG’s is desired.
- February 2020, Compumedics announced milestone US FDA approval for the Orion Life Span MEG.
Brain Monitoring Market Report Coverage
- The report offers a comprehensive quantitative as well as qualitative analysis of the current global brain monitoring market outlook and estimations from 2021 to 2031, which helps to recognize the prevalent opportunities.
- A thorough analysis of aspects that boost and restrict the development of the market is provided.
- Region-wise, as well as country-wise conditions, are broadly evaluated in this report.
- The forecasts in this report are made by examining the recent trends along with future brain monitoring market potential from 2021 to 2031 in terms of revenue.
- Major players in the market are profiled in this report and their key developmental strategies are studied in detail. This will provide an insight into the competitive landscape of the global brain monitoring industry.
Frequently Asked Questions
Q. How big is the brain monitoring market?
Ans. The global brain monitoring market size was USD 5.4 billion in 2021 and is anticipated to reach USD 10.8 billion in 2031, growing at a rate of 7.2% from 2022 to 2031.
Q. What is the brain monitoring market growth rate?
Ans. The growth rate of the brain monitoring market is 7.2% from 2022 to 2031.
Q. Which region holds a major market share for the brain monitoring market?
Ans. North America holds a major market share of the brain monitoring market in 2021.
Q. Which segment accounted for the largest brain monitoring market share?
Ans. By application, the epilepsy segment accounted for the largest brain monitoring market share
Q. Who are the key players in the brain monitoring market?
Ans. The global brain monitoring market report includes players such as Advanced Brain Monitoring, Inc., CAS Medical Systems, Inc, Compumedics Ltd, General Electric Company (GE Healthcare), Koninklijke Philips N.V. (Philips Healthcare), Medtronic Plc., Natus Medical Incorporated, Neural Analytics, Inc., Siemens AG, Cadwell Laboratories, Neurosoft Limited, Elekta A.B., InfraSacn, Inc. and BrainScope Company, Inc.
Q. What are the factors driving the brain monitoring market growth?
Ans. The major factors driving the growth of the market are the increasing volume of surgeries and the growing prevalence of severe trauma injuries.
Q. What are the key growth strategies of brain monitoring market players?
Ans. The key growth strategies of brain monitoring market players are product launch and product approval.
Q. Which region will provide more business opportunities for the brain monitoring market during the forecast period?
Ans. The Asia-Pacific region will provide more business opportunities for brain monitoring market during the forecast period
TABLE OF CONTENTS
Chapter 1. MARKET INTRODUCTION
1.1. OBJECTIVES OF THE STUDY
1.2. MARKET DEFINITION AND RESEARCH & SCOPE
1.3. RESEARCH METHODOLOGIES
1.4. MARKET ESTIMATION TECHNIQUES
Chapter 2. EXECUTIVE SUMMARY
2.1. SUMMARY
2.2. KEY HIGHLIGHTS OF THE MARKET
Chapter 3. BRAIN MONITORING MARKET OUTLOOK
3.1. BRAIN MONITORING MARKET SEGMENTATION
3.2. MARKET DYNAMICS
3.2.1. MARKET DRIVERS
3.2.1.1. DRIVER 1
3.2.1.2. DRIVER 2
3.2.1.3. DRIVER 3
3.2.2. MARKET RESTRAINTS
3.2.2.1. RESTRAINT 1
3.2.2.2. RESTRAINT 2
3.2.3. MARKET OPPORTUNITIES
3.2.3.1. OPPORTUNITY 1
3.2.3.2. OPPORTUNITY 2
3.3. PORTER’S FIVE FORCES ANALYSIS
3.3.1. THREAT OF NEW ENTRANTS
3.3.2. THREAT OF SUBSTITUTES
3.3.3. BARGAINING POWER OF BUYERS
3.3.4. BARGAINING POWER OF SUPPLIER
3.3.5. COMPETITIVE RIVALRY
3.4. PESTLE ANALYSIS
3.5. VALUE CHAIN ANALYSIS
3.5.1. RAW MATERIAL SUPPLIERS
3.5.2. MANUFACTURERS
3.5.3. WHOLESALERS AND/OR RETAILERS
3.6. IMPACT OF THE RUSSIA AND UKRAINE WAR ON THE GLOBAL BRAIN MONITORING MARKET
Chapter 4. ECONOMIC IMPACT OF COVID-19
4.1. OVERALL IMPACT OF COVID-19
4.2. IMPACT OF COVID ON THE GLOBAL BRAIN MONITORING MARKET
4.3. ECONOMIC IMPACT ANALYSIS
Chapter 5. BRAIN MONITORING MARKET BY PRODUCT TYPE
5.1. MARKET OVERVIEW
5.2. ELECTRENCEPHALOGRAPHY DEVICES
5.2.1. MARKET SIZE AND FORECAST, 2021-2031 ($MILLION)
5.2.2. MARKET SIZE AND FORECAST, BY REGION, 2021-2031 ($MILLION)
5.3. MAGNETOENCEPHALOGRAPHY DEVICES
5.3.1. MARKET SIZE AND FORECAST, 2021-2031 ($MILLION)
5.3.2. MARKET SIZE AND FORECAST, BY REGION, 2021-2031 ($MILLION)
5.4. TRANSCRANIAL DOPPLER DEVICES
5.4.1. MARKET SIZE AND FORECAST, 2021-2031 ($MILLION)
5.4.2. MARKET SIZE AND FORECAST, BY REGION, 2021-2031 ($MILLION)
5.5. INTRACRANIAL PRESSURE MONITORS
5.5.1. MARKET SIZE AND FORECAST, 2021-2031 ($MILLION)
5.5.2. MARKET SIZE AND FORECAST, BY REGION, 2021-2031 ($MILLION)
5.6. CEREBRAL OXIMETERS
5.6.1. MARKET SIZE AND FORECAST, 2021-2031 ($MILLION)
5.6.2. MARKET SIZE AND FORECAST, BY REGION, 2021-2031 ($MILLION)
5.7. MAGNETIC RESONANCE IMAGING DEVICES
5.7.1. MARKET SIZE AND FORECAST, 2021-2031 ($MILLION)
5.7.2. MARKET SIZE AND FORECAST, BY REGION, 2021-2031 ($MILLION)
5.8. COMPUTERIZED TOMOGRAPHY DEVICES
5.8.1. MARKET SIZE AND FORECAST, 2021-2031 ($MILLION)
5.8.2. MARKET SIZE AND FORECAST, BY REGION, 2021-2031 ($MILLION)
5.9. POSITRON EMISSION TOMOGRAPHY DEVICES
5.9.1. MARKET SIZE AND FORECAST, 2021-2031 ($MILLION)
5.9.2. MARKET SIZE AND FORECAST, BY REGION, 2021-2031 ($MILLION)
5.10. SLEEP MONITORING DEVICES
5.10.1. MARKET SIZE AND FORECAST, 2021-2031 ($MILLION)
5.10.2. MARKET SIZE AND FORECAST, BY REGION, 2021-2031 ($MILLION)
5.11. ELECTROMYOGRAPHY DEVICES
5.11.1. MARKET SIZE AND FORECAST, 2021-2031 ($MILLION)
5.11.2. MARKET SIZE AND FORECAST, BY REGION, 2021-2031 ($MILLION)
5.12. ACCESSORIES
5.12.1. MARKET SIZE AND FORECAST, 2021-2031 ($MILLION)
5.12.2. MARKET SIZE AND FORECAST, BY REGION, 2021-2031 ($MILLION)
Chapter 6. BRAIN MONITORING MARKET BY PROCEDURE
6.1. MARKET OVERVIEW
6.2. INVASIVE
6.2.1. MARKET SIZE AND FORECAST, 2021-2031 ($MILLION)
6.2.2. MARKET SIZE AND FORECAST, BY REGION, 2021-2031 ($MILLION)
6.3. NON-INVASIVE
6.3.1. MARKET SIZE AND FORECAST, 2021-2031 ($MILLION)
6.3.2. MARKET SIZE AND FORECAST, BY REGION, 2021-2031 ($MILLION)
Chapter 7. BRAIN MONITORING MARKET BY APPLICATION
7.1. MARKET OVERVIEW
7.2. EPILEPSY
7.2.1. MARKET SIZE AND FORECAST, 2021-2031 ($MILLION)
7.2.2. MARKET SIZE AND FORECAST, BY REGION, 2021-2031 ($MILLION)
7.3. DEMENTIA
7.3.1. MARKET SIZE AND FORECAST, 2021-2031 ($MILLION)
7.3.2. MARKET SIZE AND FORECAST, BY REGION, 2021-2031 ($MILLION)
7.4. PARKINSON’S DISEASE
7.4.1. MARKET SIZE AND FORECAST, 2021-2031 ($MILLION)
7.4.2. MARKET SIZE AND FORECAST, BY REGION, 2021-2031 ($MILLION)
7.5. HUNTINGTONS DISEASE
7.5.1. MARKET SIZE AND FORECAST, 2021-2031 ($MILLION)
7.5.2. MARKET SIZE AND FORECAST, BY REGION, 2021-2031 ($MILLION)
7.6. HEADACHE DISORDERS
7.6.1. MARKET SIZE AND FORECAST, 2021-2031 ($MILLION)
7.6.2. MARKET SIZE AND FORECAST, BY REGION, 2021-2031 ($MILLION)
7.7. STROKE
7.7.1. MARKET SIZE AND FORECAST, 2021-2031 ($MILLION)
7.7.2. MARKET SIZE AND FORECAST, BY REGION, 2021-2031 ($MILLION)
7.8. TRAUMATIC BRAIN INJURIES
7.8.1. MARKET SIZE AND FORECAST, 2021-2031 ($MILLION)
7.8.2. MARKET SIZE AND FORECAST, BY REGION, 2021-2031 ($MILLION)
7.9. SLEEP DISORDERS
7.9.1. MARKET SIZE AND FORECAST, 2021-2031 ($MILLION)
7.9.2. MARKET SIZE AND FORECAST, BY REGION, 2021-2031 ($MILLION)
7.10. OTHER
7.10.1. MARKET SIZE AND FORECAST, 2021-2031 ($MILLION)
7.10.2. MARKET SIZE AND FORECAST, BY REGION, 2021-2031 ($MILLION)
Chapter 8. BRAIN MONITORING MARKET, BY REGION
8.1. OVERVIEW
8.2. NORTH AMERICA
8.2.1. KEY MARKET TRENDS AND OPPORTUNITIES
8.2.2. NORTH AMERICA BRAIN MONITORING MARKET SIZE AND FORECAST BY PRODUCT TYPE, 2021-2031, ($MILLION)
8.2.3. NORTH AMERICA BRAIN MONITORING MARKET SIZE AND FORECAST BY PROCEDURE, 2021-2031, ($MILLION)
8.2.4. NORTH AMERICA BRAIN MONITORING MARKET SIZE AND FORECAST BY APPLICATION, 2021-2031, ($MILLION)
8.2.5. NORTH AMERICA BRAIN MONITORING MARKET SIZE AND FORECAST BY COUNTRY, 2021-2031, ($MILLION)
8.2.6. THE U.S.
8.2.6.1. THE U.S. BRAIN MONITORING MARKET SIZE AND FORECAST BY PRODUCT TYPE, 2021-2031, ($MILLION)
8.2.6.2. THE U.S. BRAIN MONITORING MARKET SIZE AND FORECAST BY PROCEDURE, 2021-2031, ($MILLION)
8.2.6.3. THE U.S. BRAIN MONITORING MARKET SIZE AND FORECAST BY APPLICATION, 2021-2031, ($MILLION)
8.2.6.4. THE U.S. BRAIN MONITORING MARKET SIZE AND FORECAST BY APPLICATION, 2021-2031, ($MILLION)
8.2.7. CANADA
8.2.7.1. CANADA BRAIN MONITORING MARKET SIZE AND FORECAST BY PRODUCT TYPE, 2021-2031, ($MILLION)
8.2.7.2. CANADA BRAIN MONITORING MARKET SIZE AND FORECAST BY PROCEDURE, 2021-2031, ($MILLION)
8.2.7.3. CANADA BRAIN MONITORING MARKET SIZE AND FORECAST BY APPLICATION, 2021-2031, ($MILLION)
8.2.8. MEXICO
8.2.8.1. MEXICO BRAIN MONITORING MARKET SIZE AND FORECAST BY PRODUCT TYPE, 2021-2031, ($MILLION)
8.2.8.2. MEXICO BRAIN MONITORING MARKET SIZE AND FORECAST BY PROCEDURE TYPE, 2021-2031, ($MILLION)
8.2.8.3. MEXICO BRAIN MONITORING MARKET SIZE AND FORECAST BY APPLICATION, 2021-2031, ($MILLION)
8.3. EUROPE
8.3.1. KEY MARKET TRENDS AND OPPORTUNITIES
8.3.2. EUROPE BRAIN MONITORING MARKET SIZE AND FORECAST BY PRODUCT TYPE, 2021-2031, ($MILLION)
8.3.3. EUROPE BRAIN MONITORING MARKET SIZE AND FORECAST BY PROCEDURE, 2021-2031, ($MILLION)
8.3.4. EUROPE BRAIN MONITORING MARKET SIZE AND FORECAST BY PLACEMENT, 2021-2031, ($MILLION)
8.3.5. EUROPE BRAIN MONITORING MARKET SIZE AND FORECAST BY APPLICATION, 2021-2031, ($MILLION)
8.3.6. EUROPE BRAIN MONITORING MARKET SIZE AND FORECAST BY COUNTRY, 2021-2031, ($MILLION)
8.3.7. GERMANY
8.3.7.1. GERMANY BRAIN MONITORING MARKET SIZE AND FORECAST BY PRODUCT TYPE, 2021-2031, ($MILLION)
8.3.7.2. GERMANY BRAIN MONITORING MARKET SIZE AND FORECAST BY PROCEDURE, 2021-2031, ($MILLION)
8.3.7.3. GERMANY BRAIN MONITORING MARKET SIZE AND FORECAST BY APPLICATION, 2021-2031, ($MILLION)
8.3.8. FRANCE
8.3.8.1. FRANCE BRAIN MONITORING MARKET SIZE AND FORECAST BY PRODUCT TYPE, 2021-2031, ($MILLION)
8.3.8.2. FRANCE BRAIN MONITORING MARKET SIZE AND FORECAST BY PROCEDURE, 2021-2031, ($MILLION)
8.3.8.3. FRANCE BRAIN MONITORING MARKET SIZE AND FORECAST BY APPLICATION, 2021-2031, ($MILLION)
8.3.9. U.K.
8.3.9.1. U.K. BRAIN MONITORING MARKET SIZE AND FORECAST BY PRODUCT TYPE, 2021-2031, ($MILLION)
8.3.9.2. U.K. BRAIN MONITORING MARKET SIZE AND FORECAST BY PROCEDURE, 2021-2031, ($MILLION)
8.3.9.3. U.K. BRAIN MONITORING MARKET SIZE AND FORECAST BY APPLICATION, 2021-2031, ($MILLION)
8.3.10. SPAIN
8.3.10.1. SPAIN BRAIN MONITORING MARKET SIZE AND FORECAST BY PRODUCT TYPE, 2021-2031, ($MILLION)
8.3.10.2. SPAIN BRAIN MONITORING MARKET SIZE AND FORECAST BY PROCEDURE, 2021-2031, ($MILLION)
8.3.10.3. SPAIN BRAIN MONITORING MARKET SIZE AND FORECAST BY APPLICATION, 2021-2031, ($MILLION)
8.3.11. ITALY
8.3.11.1. ITALY BRAIN MONITORING MARKET SIZE AND FORECAST BY PRODUCT TYPE, 2021-2031, ($MILLION)
8.3.11.2. ITALY BRAIN MONITORING MARKET SIZE AND FORECAST BY PROCEDURE, 2021-2031, ($MILLION)
8.3.11.3. ITALY BRAIN MONITORING MARKET SIZE AND FORECAST BY APPLICATION, 2021-2031, ($MILLION)
8.3.12. RUSSIA
8.3.12.1. RUSSIA BRAIN MONITORING MARKET SIZE AND FORECAST BY PRODUCT TYPE, 2021-2031, ($MILLION)
8.3.12.2. RUSSIA BRAIN MONITORING MARKET SIZE AND FORECAST BY PROCEDURE, 2021-2031, ($MILLION)
8.3.12.3. RUSSIA BRAIN MONITORING MARKET SIZE AND FORECAST BY APPLICATION, 2021-2031, ($MILLION)
8.3.13. REST OF EUROPE
8.3.13.1. REST OF EUROPE BRAIN MONITORING MARKET SIZE AND FORECAST BY PRODUCT TYPE, 2021-2031, ($MILLION)
8.3.13.2. REST OF EUROPE BRAIN MONITORING MARKET SIZE AND FORECAST BY PROCEDURE, 2021-2031, ($MILLION)
8.3.13.3. REST OF EUROPE BRAIN MONITORING MARKET SIZE AND FORECAST BY APPLICATION, 2021-2031, ($MILLION)
8.4. ASIA-PACIFIC
8.4.1. KEY MARKET TRENDS AND OPPORTUNITIES
8.4.2. ASIA-PACIFIC BRAIN MONITORING MARKET SIZE AND FORECAST BY COUNTRY, 2021-2031, ($MILLION)
8.4.3. ASIA-PACIFIC BRAIN MONITORING MARKET SIZE AND FORECAST BY PRODUCT TYPE, 2021-2031, ($MILLION)
8.4.4. ASIA-PACIFIC BRAIN MONITORING MARKET SIZE AND FORECAST BY PROCEDURE, 2021-2031, ($MILLION)
8.4.5. ASIA-PACIFIC BRAIN MONITORING MARKET SIZE AND FORECAST BY APPLICATION, 2021-2031, ($MILLION)
8.4.6. CHINA
8.4.6.1. CHINA BRAIN MONITORING MARKET SIZE AND FORECAST BY PRODUCT TYPE, 2021-2031, ($MILLION)
8.4.6.2. CHINA BRAIN MONITORING MARKET SIZE AND FORECAST BY PROCEDURE, 2021-2031, ($MILLION)
8.4.6.3. CHINA BRAIN MONITORING MARKET SIZE AND FORECAST BY APPLICATION, 2021-2031, ($MILLION)
8.4.7. INDIA
8.4.7.1. INDIA BRAIN MONITORING MARKET SIZE AND FORECAST BY PRODUCT TYPE, 2021-2031, ($MILLION)
8.4.7.2. INDIA BRAIN MONITORING MARKET SIZE AND FORECAST BY PROCEDURE, 2021-2031, ($MILLION)
8.4.7.3. INDIA BRAIN MONITORING MARKET SIZE AND FORECAST BY APPLICATION, 2021-2031, ($MILLION)
8.4.8. JAPAN
8.4.8.1. JAPAN BRAIN MONITORING MARKET SIZE AND FORECAST BY PRODUCT TYPE, 2021-2031, ($MILLION)
8.4.8.2. JAPAN BRAIN MONITORING MARKET SIZE AND FORECAST BY PROCEDURE, 2021-2031, ($MILLION)
8.4.8.3. JAPAN BRAIN MONITORING MARKET SIZE AND FORECAST BY APPLICATION, 2021-2031, ($MILLION)
8.4.9. SOUTH KOREA
8.4.9.1. SOUTH KOREA BRAIN MONITORING MARKET SIZE AND FORECAST BY PRODUCT TYPE, 2021-2031, ($MILLION)
8.4.9.2. SOUTH KOREA BRAIN MONITORING MARKET SIZE AND FORECAST BY PROCEDURE, 2021-2031, ($MILLION)
8.4.9.3. SOUTH KOREA BRAIN MONITORING MARKET SIZE AND FORECAST BY APPLICATION, 2021-2031, ($MILLION)
8.4.10. REST OF APAC
8.4.10.1. REST OF APAC BRAIN MONITORING MARKET SIZE AND FORECAST BY PRODUCT TYPE, 2021-2031, ($MILLION)
8.4.10.2. REST OF APAC BRAIN MONITORING MARKET SIZE AND FORECAST BY PROCEDURE, 2021-2031, ($MILLION)
8.4.10.3. REST OF APAC BRAIN MONITORING MARKET SIZE AND FORECAST BY APPLICATION, 2021-2031, ($MILLION)
8.5. REST OF THE WORLD
8.5.1. KEY MARKET TRENDS AND OPPORTUNITIES
8.5.2. REST OF THE WORLD BRAIN MONITORING MARKET SIZE AND FORECAST BY PRODUCT TYPE, 2021-2031, ($MILLION)
8.5.3. REST OF THE WORLD BRAIN MONITORING MARKET SIZE AND FORECAST BY PROCEDURE, 2021-2031, ($MILLION)
8.5.4. REST OF THE WORLD BRAIN MONITORING MARKET SIZE AND FORECAST BY APPLICATION, 2021-2031, ($MILLION)
8.5.5. REST OF THE WORLD BRAIN MONITORING MARKET SIZE AND FORECAST BY COUNTRY, 2021-2031, ($MILLION)
8.5.6. LATIN AMERICA
8.5.6.1. LATIN AMERICA BRAIN MONITORING MARKET SIZE AND FORECAST BY PRODUCT TYPE, 2021-2031, ($MILLION)
8.5.6.2. LATIN AMERICA BRAIN MONITORING MARKET SIZE AND FORECAST BY PROCEDURE, 2021-2031, ($MILLION)
8.5.6.3. LATIN AMERICA BRAIN MONITORING MARKET SIZE AND FORECAST BY APPLICATION, 2021-2031, ($MILLION)
8.5.7. MIDDLE EAST
8.5.7.1. MIDDLE EAST BRAIN MONITORING MARKET SIZE AND FORECAST BY PRODUCT TYPE, 2021-2031, ($MILLION)
8.5.7.2. MIDDLE EAST BRAIN MONITORING MARKET SIZE AND FORECAST BY PROCEDURE, 2021-2031, ($MILLION)
8.5.7.3. MIDDLE EAST BRAIN MONITORING MARKET SIZE AND FORECAST BY APPLICATION, 2021-2031, ($MILLION)
8.5.8. AFRICA
8.5.8.1. AFRICA BRAIN MONITORING MARKET SIZE AND FORECAST BY PRODUCT TYPE, 2021-2031, ($MILLION)
8.5.8.2. AFRICA BRAIN MONITORING MARKET SIZE AND FORECAST BY PROCEDURE, 2021-2031, ($MILLION)
8.5.8.3. AFRICA BRAIN MONITORING MARKET SIZE AND FORECAST BY APPLICATION, 2021-2031, ($MILLION)
Chapter 9. COMPETITIVE LANDSCAPE
9.1. MARKET OVERVIEW
9.2. MARKET SHARE ANALYSIS/KEY PLAYER POSITIONING
9.3. DEVELOPMENTAL STRATEGY BENCHMARKING
9.3.1. NEW PROCEDURE DEVELOPMENT
9.3.2. PRODUCT LAUNCHES
9.3.3. BUSINESS EXPANSIONS
9.3.4. PARTNERSHIPS, JOINT VENTURES, AND COLLABORATIONS
9.3.5. MERGERS AND ACQUISITIONS
Chapter 10. COMPANY PROFILES
10.1. Advanced Brain Monitoring, Inc.
10.1.1. COMPANY SNAPSHOT
10.1.2. FINANCIAL PERFORMANCE
10.1.3. PRODUCT OFFERINGS
10.1.4. KEY STRATEGIC INITIATIVES
10.1.5. SWOT ANALYSIS
10.2. CAS Medical Systems, Inc.
10.2.1. COMPANY SNAPSHOT
10.2.2. FINANCIAL PERFORMANCE
10.2.3. PRODUCT OFFERINGS
10.2.4. KEY STRATEGIC INITIATIVES
10.2.5. SWOT ANALYSIS
10.3. Compumedics Ltd.
10.3.1. COMPANY SNAPSHOT
10.3.2. FINANCIAL PERFORMANCE
10.3.3. PRODUCT OFFERINGS
10.3.4. KEY STRATEGIC INITIATIVES
10.3.5. SWOT ANALYSIS
10.4. General Electric Company (GE Healthcare)
10.4.1. COMPANY SNAPSHOT
10.4.2. FINANCIAL PERFORMANCE
10.4.3. PRODUCT OFFERINGS
10.4.4. KEY STRATEGIC INITIATIVES
10.4.5. SWOT ANALYSIS
10.5. Koninklijke Philips N.V. (Philips Healthcare)
10.5.1. COMPANY SNAPSHOT
10.5.2. FINANCIAL PERFORMANCE
10.5.3. PRODUCT OFFERINGS
10.5.4. KEY STRATEGIC INITIATIVES
10.5.5. SWOT ANALYSIS
10.6. Medtronic Plc.
10.6.1. COMPANY SNAPSHOT
10.6.2. FINANCIAL PERFORMANCE
10.6.3. PRODUCT OFFERINGS
10.6.4. KEY STRATEGIC INITIATIVES
10.6.5. SWOT ANALYSIS
10.7. Natus Medical Incorporated
10.7.1. COMPANY SNAPSHOT
10.7.2. FINANCIAL PERFORMANCE
10.7.3. PRODUCT OFFERINGS
10.7.4. KEY STRATEGIC INITIATIVES
10.7.5. SWOT ANALYSIS
10.8. Neural Analytics, Inc.
10.8.1. COMPANY SNAPSHOT
10.8.2. FINANCIAL PERFORMANCE
10.8.3. PRODUCT OFFERINGS
10.8.4. KEY STRATEGIC INITIATIVES
10.8.5. SWOT ANALYSIS
10.9. Siemens AG
10.9.1. COMPANY SNAPSHOT
10.9.2. FINANCIAL PERFORMANCE
10.9.3. PRODUCT OFFERINGS
10.9.4. KEY STRATEGIC INITIATIVES
10.9.5. SWOT ANALYSIS
10.10. Cadwell Laboratories
10.10.1. COMPANY SNAPSHOT
10.10.2. FINANCIAL PERFORMANCE
10.10.3. PRODUCT OFFERINGS
10.10.4. KEY STRATEGIC INITIATIVES
10.10.5. SWOT ANALYSIS
10.11. Neurosoft Limited
10.11.1. COMPANY SNAPSHOT
10.11.2. FINANCIAL PERFORMANCE
10.11.3. PRODUCT OFFERINGS
10.11.4. KEY STRATEGIC INITIATIVES
10.11.5. SWOT ANALYSIS
10.12. Elekta A.B.
10.12.1. COMPANY SNAPSHOT
10.12.2. FINANCIAL PERFORMANCE
10.12.3. PRODUCT OFFERINGS
10.12.4. KEY STRATEGIC INITIATIVES
10.12.5. SWOT ANALYSIS
10.13. InfraSacn, Inc.
10.13.1. COMPANY SNAPSHOT
10.13.2. FINANCIAL PERFORMANCE
10.13.3. PRODUCT OFFERINGS
10.13.4. KEY STRATEGIC INITIATIVES
10.13.5. SWOT ANALYSIS
10.14. BrainScope Company, Inc.
10.14.1. COMPANY SNAPSHOT
10.14.2. FINANCIAL PERFORMANCE
10.14.3. PRODUCT OFFERINGS
10.14.4. KEY STRATEGIC INITIATIVES
10.14.5. SWOT ANALYSIS
*The list of company is subject to change during the final compilation of the report
Key Players
- Advanced Brain Monitoring, Inc.
- CAS Medical Systems, Inc.
- Compumedics Ltd.
- General Electric Company (GE Healthcare)
- Koninklijke Philips N.V. (Philips Healthcare)
- Medtronic Plc.
- Natus Medical Incorporated
- NovaSignal
- Siemens AG
- Cadwell Laboratories
- Neurosoft Limited
- Elekta A.B.
- InfraSacn, Inc.
- BrainScope Company, Inc.
Market Segments
By Product Type
- Electroencephalography (EEG) Devices
- Magnetoencephalography (MEG) Devices
- Transcranial Doppler (TCD) Devices
- Intracranial Pressure (ICP) Monitors
- Cerebral Oximeters
- Magnetic Resonance Imaging (MRI) Devices
- Computerized Tomography (CT) Devices
- Positron Emission Tomography (PET) Devices
- Sleep Monitoring Devices
- Electromyography (EMG) Devices
- Accessories
By Procedure
- Invasive
- Non-invasive
By Application
- Epilepsy
- Dementia
- Parkinson’s Disease
- Huntington’s Disease
- Headache Disorders
- Stroke
- Traumatic Brain Injuries
- Sleep Disorders
- Other Diseases
By Region
- North America
- The U.S.
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Spain
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Rest of World
- Latin America
- Middle East
- Africa